Therapy, Pain & Training
Training in Hypoxia – Altitude Training

Hypoxic Training in Natural and Artificial Altitude

Hypoxietraining in natürlicher und künstlicher Höhe


Many endurance athletes aim to increase endurance performance at or near sea-level by hypoxic training, which can be realized in natural or artificial altitude via three main concepts: living and training in hypoxia, living in hypoxia and training in normoxia, or living in normoxia and training in hypoxia.

The scientific evidence for these concepts is surprisingly unclear, although several ergogenic adaptations to hypoxic training are well described. Hematologic acclimatization through an increase in hemoglobin mass is often considered the most important factor. But hematologic acclimatization does not explain the performance increase found by some studies, indicating other mechanisms and confounders determine successful training adaptation.

This clinical review briefly summarizes the current, conflicting knowledge, lists confounders potentially influencing the outcome, and provides some practical guidance to coaches and clinicians for monitoring and optimizing hypoxic training as far as covered by evidence.

Key Words: Hypoxia, Endurance Performance, Wearables, Elite Athletes, Endurance Training, Hemoglobin, Erythropoiesis


Beginning with the 1968 Olympic Games in Mexico, hypoxia training has become a regularly used method by elite endurance athletes and numerous national athletic programs to prepare for altitude or (near) sea-level competitions (2, 22, 37). This clinical review focuses on the aim of improving sea-level performance through hypoxic training at natural or simulated moderate altitude in highly trained and elite endurance athletes. There is a considerable and growing body of scientific literature on this topic, but the evidence is by no means conclusive [e.g., (19, 34)]. Here, we aim to summarize the existing knowledge of altitude training for increasing sea-level performance, to highlight the ambiguities, and to outline guiding principles within the narrow corridors of evidence.


Hypoxia is a deficiency of oxygen on the tissue level. In healthy humans, hypoxia can occur during severe intensity exercise, but typically it is due to a lack of oxygen in inspired air. This may be due to “natural” altitude, where barometric pressure is lower and thus partial pressure for oxygen is reduced (i.e., hypobaric hypoxia). At natural altitude, other environmental factors also change, i.e., lower air temperature, humidity, and density, but higher radiation and ozone exposure. “Artificial” altitude is most commonly induced by lower oxygen concentration in an otherwise unchanged environment at ambient air pressure (i.e., normobaric hypoxia). Acclimatization to natural and artificial hypoxia is generally very similar (29) and thus training adaptations are similar, despite differences in e.g., ventilatory response, fluid balance, or risk of acute altitude illness (20).

Hypoxia causes a decrease of maximum oxygen uptake (V˙O2max) that amounts to roughly 6.0-7.5%/1000 m altitude in not acclimatized endurance athletes and is detectable from 300-800 m onwards (5, 45). As a consequence, time trial performance (i.e., exercise lasting more than 2 min) decreases by approximately 6.5–7%/1000 m after acute exposure (5, 6). Humans can acclimatize to hypoxia to a certain extent, but even at 2300 m altitude this is incomplete, so that performance remains ~6% below that at sea level even after 3 weeks of altitude acclimatization (33). Despite the detrimental effects of hypoxia on performance, certain aspects of altitude acclimatization may have the potential to improve performance in normoxia.

General and Performance-Related Aspects of Acclimatization to Hypoxia

Individual responses to hypoxia occur after only a few seconds and extend over minutes, weeks, and even years, depending on the degree of hypoxia and continuity of exposure. In order to optimize training programming and to effectively use altitude training within a long-term periodized approach, it is important to consider the temporal dynamics of the acclimatization illustrated in Figure 1.

The most obvious and nearly immediate response to hypoxia is hyperventilation, which is an essential and very effective compensatory mechanism directly improving arterial O2-content, causing a higher ventilation at a given power output. Hyperventilation does not only increase alveolar PO2, but also induces a respiratory alkalosis due to the reduction of alveolar and arterial PCO2, imposing a transient left shift of the oxygen dissociation curve. In moderate altitudes, alkalosis is renally compensated within 24 h, but the price to pay is a decreased buffer capacity due to the loss of hydrogen bicarbonate. However, at moderate altitude a rightward shift of the oxygen-dissociation curve is observed due to the higher concentration of 2.3-BPG. Particularly during exercise, this right shift facilitates dissociation of oxygen from hemoglobin to the tissue counteracting the impaired alveolar oxygen extraction (17). It is also worth mentioning that the young erythrocytes who also have beneficial rheological properties and higher 2.3-BPG concentration are not hemolyzed after return to sea level (14).

A substantial increase of resting and sub-maximum heart rate is another, very rapid response that augments cardiac output and thus helps to maintain the oxygen supply to the tissue. This response is mediated by a hypoxia-induced shift of the autonomic nervous system towards sympathetic dominance, which is a systemic reaction. Recent data from 3450 m indicate that this reaction may be attenuated in highly endurance-trained athletes, leading to an impaired acclimatization on the first day that has to be considered in training planning (28). Of note, both heart rate and ventilation are significantly altered so that these two variables are no longer linked to exercise intensity as they are at sea level.

A more delayed response is a plasma volume shrinkage of ~6% after one day. Due to this loss of volume, hemoglobin concentration increases by approximately 0.6 g/dL at 2500 m (1), causing a higher amount of oxygen carriers per unit of blood, but notably not to an increase in absolute oxygen transport capacity. In turn, the lower blood volume decreases cardiac pre-load and thus sub-maximum and maximum cardiac stroke volume, to which also the shortened diastolic filling time due to the increased heart rate contributes. Both have a negative effect on cardiac output and consequently on V˙O2max (35).

But these early reactions cannot fully compensate for the PO2 decrease in tissues, mediating a stabilization of hypoxia-inducible factors (HIF 1α, 2α). As a result, transcription and translation of the erythropoietin (EPO) gene are stimulated and within 2 h an increase in serum [EPO] is observed, peaking after 2-3 days at altitude. [EPO] may decrease to baseline in the following days and weeks of hypoxic exposure (eg., (44)), but magnitude and time course seem to depend on the degree of hypoxia. EPO initiates erythropoiesis and an increasing number of reticulocytes can be detected in the blood after 3-5 days, imposing an absolute increase in hemoglobin mass (Hbmass) of ~2% after 10 days at 2300 m (44). A substantial ~4-5% increase can be expected after 3 weeks and studies lasting 4 weeks did not observe a leveling off at 2300 m (27). The increase in Hbmass is a true increase in oxygen transport capacity of the blood. It is probably the most prominent aspect of acclimatization expected to improve performance at sea level, since a change of 1 g hemoglobin mass is associated with an increase in V˙O2max of approximately 4 mL/min (32). The Hbmass increase is very heterogeneous and data reported range from no response to 12% (44). Figure 2 mirrors potential and proven confounders contributing to this variability.

Aside from these effects, responses to training in hypoxia have been reported in a variety of skeletal muscle cell types and other tissues by measuring mRNA level (43), which must not be interpreted in isolation. Several aspects of acclimatization are related to the hypoxia mediated HIF-stabilization that does not only increase [EPO], but also impacts vascular endothelial growth factor, glycolytic enzymes, monocarboxylate transporter 1 and 4, and other variables that influence metabolism and thereby performance (see (11) for review and references). Receptors for EPO itself are to be found on a variety of tissues, suggesting an influence of EPO on angiogenesis and possibly indicating a cardioprotective function (see (46) for review).

Hypoxia Training Concepts

Traditionally, athletes traveled to altitude to sleep and train. But for the last 30 years other concepts have been developed that can also be combined with each other (Figure 3).

Live High – Train High (LH-TH)
The traditional LH-TH camps are designed especially for endurance athletes. Here, athletes sleep and train at altitude. Camps usually last 2-3 weeks and are sometimes held for two to three times per season. Optimum altitude for increasing hemoglobin mass is probably 1800–2500 m. Due to hypoxia, performance capacity decreases, necessitating a reduction of external training load.

Live High – Train Low (LH-TL)
Finnish and American scientists created the LH-TL concept in the early 1990s to circumvent the reduction in external training load and potential loss of strength. In LH-TL, athletes live and/or sleep either at natural or artificial altitude and train in normoxic (i.e., near sea-level) conditions. Due to logistical difficulties of realizing LH-TL in the mountains (travel time etc.), artificial altitude is generally preferred. But the opposite way been has also reported, i.e., to live in natural altitude and then to train in approximated normoxia by supplementing oxygen (47). To induce effective erythropoiesis, exposure to hypoxia should last ≥14 h/day for 2-3 weeks at natural or simulated altitude ≥2100 m (31).

Evidence of Increase in Endurance Performance after Living High Camps
In elite athletes, performance increases of 5.2% after LH-TH (~2400 m) and 4.3% after LH-TL camps (~2900 m) were calculated, clearly indicating that such training concepts can be successful. However, these results are based on a limited selection of studies (2). Due to the high individual variability, numerous methodologically limited studies, and contradictory results even within the few high-quality studies, we do not see reliable evidence for performance improvements after LH-TH or LH-TL.
Nevertheless, considerable performance improvements have also been reported for combined concepts, called LH-THTL. Here, athletes live and sleep in hypoxia (LH) and they conduct low- and moderate-intensity training in hypoxia (TH), which contributes the largest proportion of an endurance athlete’s schedule. Of note, they generally perform high-intensity training sessions in normoxia (TL) to circumvent reductions in external load (27).

To explain the ambiguity in the data, it is worth mentioning that timing of testing and/or competing are crucial for the outcome, but exact data are scarce. According to our experience, few athletes demonstrate a first peak in performance 1-3 days after return to normoxia, followed by a 2-week low in performance, which is similar to data of (21). Maximum performance is usually achieved after approximately 3 weeks, which is in line with scientific data on swimmers, for both competition and standardized testing. However, at that time point, ~50% of the Hbmass increase is already lost on the time course, underlining that the gain in performance is only partially attributable to hematological acclimatization (44).

Live Low – Train High (LL-TH)
With live low–train high (LL-TH), athletes train in hypoxia, while spending the remaining time in normoxia. This concept has gained enormous popularity in recent years. It is applied for medical purposes such as improving rehabilitation intervention outcomes (24) and by athletes, e.g., from team sports, who can hardly participate in live high-training camps for practical reasons, like e.g., their tournament schedule. At least three different LL-TH protocols are applied (for review see (10)).

1. Continuous hypoxic training (CHT), where athletes perform at least 20-min lasting bouts of moderate intensity exercise in order to improve low intensity endurance performance.
2. Interval training in hypoxia (IHT), where athletes conduct moderate to high intensity interval exercise lasting 0.5 – 5.0 min. The pause is similar to the duration of the preceding work interval. Aim is to improve V˙O2max.
3. Repetitive sprint training in hypoxia (RSH), where athletes perform short (5-30 s) high-intensity exercise with incomplete recovery times (20-180 s). Here, athletes aim to reduce fatigue of repeated sprinting, which can be particularly relevant for team sports like e.g., soccer (3).

Evidence of Increase in Exercise Performance after Living Low Camps
With none of these concepts the time in hypoxia necessitated for effective erythropoiesis is achieved, consequently erythropoietic effects have not been reported. However, acclimatization may involve other molecular changes, which do not necessarily but possibly allow for a detectable aerobic adaptation. These include increased citrate synthase activity, mitochondrial density, capillary-muscle fiber ratio, muscle fiber cross-section, increased mitochondrial biogenesis, altered carbohydrate and mitochondrial metabolism, or defense against oxidative stress and improved buffer capacity (4,8).

Enhancements of sea-level performance following CHT or IHT and their combination with normoxic training are controversially discussed (10, 18), and there are also no convincing data for intermittent hypoxic exposure (i.e. , hypoxia without exercise) or resistance training in hypoxia.

RSH, on the other hand, is a relatively young approach that has attracted great scientific and practical interest. The majority of studies describe improved resistance to fatigue in repeated sprints (1–5%) without improvement in maximum sprint performance (3).

Aside from these endurance training-based concepts, resistance training in hypoxia (RTE) or intermittent hypoxic exposure (IHE) may provide benefits for athletes to prepare for sojourn, training, or competition at altitude, but we are not aware of any data proving ergogenic effects for sea-level performance.

Repeated Application of Hypoxic Training Camps and Periodization
Hypoxic training is not limited to a single training camp per season (e.g., before an important competition), but can be applied repeatedly throughout the season to benefit from previous acclimatization to accumulate ergogenic effects (German: “Höhenkette”). We are not aware of detailed data on the prevalence of such periodization, but we consider it to be relatively common and it is certainly applied by top athletes (37). However, data allowing us to judge its effectiveness are scarce. Saunders et al. for example reported a consecutively accumulated 10% increase in Hbmass in four swimmers within a 3-4 year period that incorporated several hypoxic exposures, but these data do neither show how muscle mass developed (which is closely correlated to Hbmass (42)), nor have training details or other confounders been reported (30). However, there is evidence that altitude acclimatization can be preserved in terms of arterial oxygenation and improved exercise capacity at 5 and 21 days after descent, though not mirrored by increased [Hb] (40). Metabolomic profiling added molecular elements to the puzzle, indicating an adenosine-dependent “erythrocyte hypoxic memory” potentially contributing to the positive effects (38, 41). Generally, it has been suggested to keep a duration of at least 8 weeks between altitude training camps to prevent excessive fatigue and to be able to periodize the training reasonably in the normoxia phases (26), but also shorter durations have been reported (37).

Confounding Factors and Practical Applications

Several confounding factors need to be acknowledged when interpreting the response to hypoxic training in scientific studies and individual athletes. To monitor, control, and optimize these factors is key for practical and successful application of hypoxic training.

Sufficient iron availability is a precondition for successful erythropoiesis. Thus, it is imperative to assess iron metabolism long term before a hypoxic training intervention and to consider appropriate supplementation. Following recent recommendations, ferritin concentrations <15 µg/L represent the threshold for considering parenteral iron supplementation due to a severe iron-deficiency restricting erythropoiesis. If ferritin is <35 µg/L, a sports physician should also be contacted to discuss immediate oral supplementation. Even with higher ferritin concentrations ranging 100-130 μg/L, oral supplementation of 100 mg/day elemental iron is recommended before and/or at least during a hypoxic camp by Australian experts (39). Other researchers, in contrast, did not report a benefit from ferritin concentrations higher than 35 μg/L pre altitude or from iron supplementation in respect to Hbmass increase in endurance athletes with clinically normal iron stores (15). However, findings remain controversial (12).

In order to maintain health and training adaptivity in normoxia, it is essential to meet the energy demand and also to avoid relative energy deficiency in sports. This is especially true in hypoxia, where resting metabolic rate increases with altitude and time at moderate altitude (48). To reduce the potentially detrimental influence of increased oxidative stress in hypoxia (13) it is actually recommended to integrate ample amounts of antioxidant-rich foods (e.g., orange juice) into athletes’ daily dietary regime, but antioxidant supplements are currently not recommended as they might even impair desired effects (39).
Generally, a decrease in external training load is strongly recommended and successful coaches agree that the completion of the training volume has a higher priority than intensity [own observation]. Especially during the first days at an altitude of 3450 m, not acclimatized endurance-trained athletes are at higher risk for developing acute mountain sickness compared to untrained controls (28). This indicates pre-acclimatization and/or a substantial reduction in external load.

The overall time course of acclimatization is partly attributable to the response of the autonomic nervous system (36), which can be estimated via heart rate variability if standardized conditions are applied (28). Blood oxygen saturation is a surrogate of acclimatization that can be monitored non-invasively with oxygen pulse monitors. The rapidly advancing development of wearable technology, e.g., wrist-worn devices regularly used by endurance athletes to track their training, is promising a continuously assessment of such measures (16). Such monitoring might be especially useful to quantify the individual “hypoxic dose” (9) at rest, exercise, and during sleep, because also nocturnal blood deoxygenation has the potential to contribute to hematological and ventilatory acclimatization (23).

Another potential confounder (or determinant) is exercise induced arterial hypoxemia (EIAH), which is a persistent decrease of arterial PO2 in a normoxic environment of at least 10 mmHg (roughly corresponding to -4% on a pulse oximeter) from rest to exercise (25). Currently it is unclear, how the degree of EIAH in normoxia is related to its magnitude occurring in hypoxia, if one or the other facilitates or impairs acclimatization, as is the contribution of EIAH to the heterogeneity of the adaptation to hypoxic training (7).

Impairment of erythropoiesis and performance occurs when athletes become ill or injured during altitude training, consequently Hbmass does not increase or even decreases (15, 44). According to our experience, non-steroidal pain medication might also mitigate desired effects. Finally, it has to be noted that the heterogeneity of evidence might partly be attributable to unreported or unknown applications of EPO or blood doping methods in particular studies. Altogether we believe that these confounding factors, either individually or in combination, contributed substantially to the heterogeneous results in the literature and explain a large proportion of the so-called non-responders.


Despite the extensive body of literature, clear evidence and practical guidelines how hypoxic training allows for an increase in endurance performance at sea level is still lacking. What does seem clear, however, is that healthy athletes can increase their hemoglobin mass through hypoxia, and thus their oxygen transport capacity, given a sufficient hypoxic dose, energy and iron availability. However, this relatively well-controllable part of acclimatization only partially explains the performance improvement reported by some studies. Other aspects of non-hematological ergogenic acclimatization are still incompletely understood, as are the numerous confounders that can explain non-adaptation to hypoxic-training. We recommend to monitor and – if possible – manage confounders as best as possible before, during, and after a hypoxic intervention to allow for subsequent, individual optimization.

Conflict of Interest
The authors have no conflict of interest.


  1. BEIDLEMAN BA, STAAB JE, MUZA SR, SAWKA MN. Quantitative modelof hematologic and plasma volume responses after ascentand acclimation to moderate to high altitudes. Am J PhysiolRegul Integr Comp Physiol. 2017; 312: R265-R272.
  2. BONETTI DL, HOPKINS WG. Sea-level exercise performance followingadaptation to hypoxia: a meta-analysis. Sports Med. 2009; 39:107-127.
  3. BROCHERIE F, GIRARD O, FAISS R, MILLET GP. Effects of Repeated-Sprint Training in Hypoxia on Sea-Level Performance: A Meta-Analysis. Sports Med. 2017; 47: 1651-1660.
  4. BROCHERIE F, MILLET GP, D’HULST G, VAN THIENEN R, DELDICQUE L,GIRARD O. Repeated maximal-intensity hypoxic exercisesuperimposed to hypoxic residence boosts skeletal muscletranscriptional responses in elite team-sport athletes. ActaPhysiol (Oxf). 2018; 222: e12989.
  5. CLARK SA, BOURDON PC, SCHMIDT W, SINGH B, CABLE G, ONUS KJ,WOOLFORD SM, STANEF T, GORE CJ, AUGHEY RJ. The effect of acutesimulated moderate altitude on power, performance and pacingstrategies in well-trained cyclists. Eur J Appl Physiol. 2007; 102:45-55.
  6. DEB SK, BROWN DR, GOUGH LA, MCLELLAN CP, SWINTON PA, ANDYSPARKS S, MCNAUGHTON LR. Quantifying the effects of acutehypoxic exposure on exercise performance and capacity: Asystematic review and meta-regression. Eur J Sport Sci. 2018; 18:243-256.
  7. DURAND F, RABERIN A. Exercise-Induced Hypoxemia in EnduranceAthletes: Consequences for Altitude Exposure. Front Sports ActLiving. 2021; 3: 663674.
  8. FAISS R, LÉGER B, VESIN JM, FOURNIER PE, EGGEL Y, DÉRIAZ O, MILLET GP. Significant molecular and systemic adaptations afterrepeated sprint training in hypoxia. PLoS One. 2013; 8: e56522.
  9. GARVICAN-LEWIS LA, SHARPE K, GORE CJ. Time for a new metric forhypoxic dose. J Appl Physiol (1985). 2016; 121: 352-5.
  10. GIRARD O, BROCHERIE F, GOODS PSR, MILLET GP. An UpdatedPanorama of “Living Low-Training High” Altitude/HypoxicMethods. Front Sports Act Living. 2020; 2: 26.
  11. GORE CJ, CLARK SA, SAUNDERS PU. Nonhematological mechanismsof improved sea-level performance after hypoxic exposure.Med Sci Sports Exerc. 2007; 39: 1600-1609.
  12. GOVUS AD, GARVICAN-LEWIS LA, ABBISS CR, PEELING P, GORE CJ. Pre-Altitude Serum Ferritin Levels and Daily Oral Iron SupplementDose Mediate Iron Parameter and Hemoglobin Mass Responsesto Altitude Exposure. PLoS One. 2015; 10: e0135120.
  13. J WADLEY A. S Svendsen I, Gleeson M. Heightened Exercise-Induced Oxidative Stress at Simulated Moderate Level Altitudevs. Sea Level in Trained Cyclists. Int J Sport Nutr Exerc Metab.2017; 27: 97-104.
  14. KLEIN M, KAESTNER L, BOGDANOVA AY, MINETTI G, RUDLOFF S, LUNDBY C,MAKHRO A, SEILER E, VAN CROMVOIRT A, FENK S, SIMIONATO G, HERTZ L,RECKTENWALD S, SCHÄFER L, HAIDER T, FRIED S, BORSCH C, MARTI HH,SANDER A, MAIRBÄURL H. Absence of neocytolysis in humansreturning from a 3-week high-altitude sojourn. Acta Physiol(Oxf). 2021; 232: e13647.
  15. KOIVISTO-MØRK AE, SVENDSEN IS, SKATTEBO Ø, HALLÉN J, PAULSEN G. Impact of baseline serum ferritin and supplemental iron onaltitude-induced hemoglobin mass response in elite athletes.Scand J Med Sci Sports. 2021; 31: 1764-1773.
  16. SCHIEFER L, TREFF G, TREFF F, SCHMIDT P, SCHÄFER L, NIEBAUER J,SWENSON KE, SWENSON ER, BERGER MM, SAREBAN M. Validity ofPeripheral Oxygen Saturation Measurements with the GarminFenix(R) 5X Plus Wearable Device at 4559 m. Sensors. 2021; 21:6363.
  17. MAIRBÄURL H. Red blood cell function in hypoxia ataltitude and exercise. Int J Sports Med. 1994; 15: 51-63.
  18. MCLEAN BD, GORE CJ, KEMP J. Application of ‘live low-train high’for enhancing normoxic exercise performance in team sportathletes. Sports Med. 2014; 44: 1275-1287.
  19. MILLET GP, BROCHERIE F. Hypoxic Training Is Beneficial in EliteAthletes. Med Sci Sports Exerc. 2020; 52: 515-518.
  20. MILLET GP, FAISS R, PIALOUX V. Point: Hypobaric hypoxia inducesdifferent physiological responses from normobaric hypoxia.J Appl Physiol (1985). 2012; 112: 1783-1784.
  21. MILLET GP, ROELS B, SCHMITT L, WOORONS X, RICHALET JP. Combininghypoxic methods for peak performance. Sports Med. 2010; 40:1-25.
  22. MUJIKA I, SHARMA AP, STELLINGWERFF T. ContemporaryPeriodization of Altitude Training for Elite Endurance Athletes:A Narrative Review. Sports Med. 2019; 49: 1651-1669.
  23. PIALOUX V, BRUGNIAUX JV, FELLMANN N, RICHALET JP, ROBACH P,SCHMITT L, COUDERT J, MOUNIER R. Oxidative stress and HIF-1alpha modulate hypoxic ventilatory responses after hypoxictraining on athletes. Respir Physiol Neurobiol. 2009; 167: 217-220.
  24. PRAMSOHLER S, BURTSCHER M, FAULHABER M, GATTERER H,RAUSCH L, ELIASSON A, NETZER NC. Endurance Training inNormobaric Hypoxia Imposes Less Physical Stress for GeriatricRehabilitation. Front Physiol. 2017; 8: 514.
  25. PREFAUT C, DURAND F, MUCCI P, CAILLAUD C. Exercise-inducedarterial hypoxaemia in athletes: a review. Sports Med. 2000; 30:47-61.
  26. ROBERTSON EY, SAUNDERS PU, PYNE DB, AUGHEY RJ, ANSON JM, GORE CJ. Reproducibility of Performance Changes to Simulated LiveHigh/Train Low Altitude. Med Sci Sports Exerc. 2010; 42: 394-401.
  27. RODRÍGUEZ FA, IGLESIAS X, FERICHE B, CALDERÓN-SOTO C, CHAVERRI D,WACHSMUTH NB, SCHMIDT W, LEVINE BD. Altitude Training inElite Swimmers for Sea Level Performance (Altitude Project).Med Sci Sports Exerc. 2015; 47: 1965-1978.
  28. SAREBAN M, SCHIEFER LM, MACHOLZ F, SCHÄFER L, ZANGL Q, INAMA F,REICH B, MAYR B, SCHMIDT P, HARTL A, BÄRTSCH P, NIEBAUER J, TREFF G,BERGER MM. Endurance Athletes Are at Increased Risk for EarlyAcute Mountain Sickness at 3450 m. Med Sci Sports Exerc. 2020;52: 1109-1115.
  29. SAUGY JJ, SCHMITT L, HAUSER A, CONSTANTIN G, CEJUELA R, FAISS R,WEHRLIN JP, ROSSET J, ROBINSON N, MILLET GP. Same PerformanceChanges after Live High-Train Low in Normobaric vs. HypobaricHypoxia. Front Physiol. 2016; 7: 138.
  30. SAUNDERS PU, GARVICAN-LEWIS LA, CHAPMAN RF, PÉRIARD JD. SpecialEnvironments: Altitude and Heat. Int J Sport Nutr Exerc Metab.2019; 29: 210-219.
  31. SCHMIDT W, PROMMER N. Effects of various training modalitieson blood volume. Scand J Med Sci Sports. 2008; 18: 57-69.
  32. SCHMIDT W, PROMMER N. Impact of alterations in total hemoglobinmass on V˙O2max. Exerc Sport Sci Rev. 2010; 38: 68-75.
  33. SCHULER B, THOMSEN JJ, GASSMANN M, LUNDBY C. Timing the arrivalat 2340 m altitude for aerobic performance. Scand J Med SciSports. 2007; 17: 588-594.
  34. SIEBENMANN C, DEMPSEY JA. Hypoxic Training Is Not Beneficialin Elite Athletes. Med Sci Sports Exerc. 2020; 52: 519-522.
  35. SIEBENMANN C, HUG M, KEISER S, MÜLLER A, VAN LIESHOUT J,RASMUSSEN P, LUNDBY C. Hypovolemia explains the reduced strokevolume at altitude. Physiol Rep. 2013; 1: e00094.
  36. SIEBENMANN C, LUNDBY C. Regulation of cardiac output in hypoxia.Scand J Med Sci Sports. 2015; 25: 53-59.
  37. SOLLI GS, TØNNESSEN E, SANDBAKK Ø. The Training Characteristicsof the World’s Most Successful Female Cross-Country Skier.Front Physiol. 2017; 8: 1069. doi:10.3389/fphys.2017.01069.
  39. STELLINGWERFF T, PEELING P, GARVICAN-LEWIS LA, HALL R, KOIVISTO AE,HEIKURA IA, BURKE LM. Nutrition and Altitude: Strategies toEnhance Adaptation, Improve Performance and MaintainHealth: A Narrative Review. Sports Med. 2019; 49: 169-184.
  41. SUN K, LIU H, SONG A, MANALO JM, D‘ALESSANDRO A, HANSEN KC,KELLEMS RE, ELTZSCHIG HK, BLACKBURN MR, ROACH RC, XIA Y. Erythrocyte purinergic signaling components underlie hypoxiaadaptation. J Appl Physiol (1985). 2017; 123: 951-956.
  42. TREFF G, SCHMIDT W, WACHSMUTH N, VÖLZKE C, STEINACKER JM. Total Haemoglobin Mass, Maximal and SubmaximalPower in Elite Rowers. Int J Sports Med. 2013; 35: 571-574.
  43. VOGT M, PUNTSCHART A, GEISER J, ZULEGER C, BILLETER R, HOPPELER H. Molecular adaptations in human skeletal muscle to endurancetraining under simulated hypoxic conditions. J Appl Physiol(1985). 2001; 91: 173-82.
  44. WACHSMUTH NB, VÖLZKE C, PROMMER N, SCHMIDT-TRUCKSÄSS A, FRESE F,SPAHL O, EASTWOOD A, STRAY-GUNDERSEN J, SCHMIDT W. The effects ofclassic altitude training on hemoglobin mass in swimmers. Eur JAppl Physiol. 2013; 113: 1199-1211.
  45. WEHRLIN JP, HALLEN J. Linear decrease in V˙O2max andperformance with increasing altitude in endurance athletes. EurJ Appl Physiol. 2006; 96: 404-412.
  46. WENGER RH, KURTZ A. Erythropoietin. Compr Physiol. 2011; 1: 1759-1794.
  47. WILBER RL. Current trends in altitude training. Sports Med. 2001;31: 249-265.
  48. WOODS AL, SHARMA AP, GARVICAN-LEWIS LA, SAUNDERS PU, RICE AJ,THOMPSON KG. Four Weeks of Classical Altitude TrainingIncreases Resting Metabolic Rate in Highly Trained Middle-Distance Runners. Int J Sport Nutr Exerc Metab. 2017; 27: 83-90.
PD Dr. Gunnar Treff
Paracelsus Medical University
University Institute of Sports Medicine,
Prevention and Rehabilitation
Lindhofstraße 20, 5020 Salzburg, Austria